zie bijlage 1

Following the second Information Notice, we hereby inform you that the contracting authority has decided to temporarily withdraw the current European tender procedure EA Neoantigen Peptides for therapeutic purpose. The reason for this decision is that the contracting authority is considering removing one of the specified requirements and potentially revising other parts of the original tender documents. This reconsideration may affect the content and scope of the procedure, and therefore requires careful reassessment before any further steps are taken. Should you wish to object to this withdrawal, we kindly request that you submit your objection in writing no later than seven (7) calendar days from the date of this publication. After review of the tender documents, the procedure may be relaunched at a later stage, either in its original or a revised form. We thank you for your understanding and cooperation. Esen Alatag [email protected] 0631135742.